ArticleCancers2018

Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro Study.

Lucyna Matusewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.